Ticker
FENCCompany Name
FENNEC PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -8.49M | -25.51% | $ 33.3M |
3/31/2025 | $ -10.45M | -33.79% | $ 30.91M |
12/31/2024 | $ 4M | 8.41% | $ 47.54M |
9/30/2024 | $ 3.79M | 7.68% | $ 49.35M |
6/30/2024 | $ 7.49M | 15.32% | $ 48.89M |
3/31/2024 | $ 7.38M | 16.42% | $ 44.95M |
12/31/2023 | $ -12.65M | -59.53% | $ 21.25M |
9/30/2023 | $ -17M | -130.23% | $ 13.05M |
6/30/2023 | $ -23.96M | -366.47% | $ 6.54M |
3/31/2023 | $ -24.35M | -758.16% | $ 3.21M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for FENNEC PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -18.48M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]
Minimum
Mar 31, 2021
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.54% |
median | 9.01% |
std | 23.96% |